Healthier At-home Meals for Expectant Mothers

NCT ID: NCT05605340

Last Updated: 2025-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-09

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being done to test the feasibility, acceptability, and preliminary efficacy of a meal delivery intervention for managing gestational weight gain among pregnant women with overweight or obesity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Related Weight Gain, Maternal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All participants enrolled will receive the study intervention. A quasi-experimental design will be used to investigate the preliminary efficacy of the meal delivery intervention on gestational weight gain and estimate the effect size of the intervention relative to a non-randomized standard care but weighted control group derived from de-identified hospital records.
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

All participants enrolled will receive the study intervention, so blinding is not possible.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Meal delivery intervention with brief behavioral support.

Group Type EXPERIMENTAL

Meal Delivery

Intervention Type BEHAVIORAL

10 healthy, home-delivered meals per week + brief weekly remote behavioral support

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Meal Delivery

10 healthy, home-delivered meals per week + brief weekly remote behavioral support

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Gestational age ≤ 15 weeks as assessed by ultrasound
* Body mass index (BMI) ≥ 25 kg/m2
* Singleton viable pregnancy
* Receiving care and planning to deliver at UAB
* Residing within the delivery radius of the meal delivery company
* Wi-Fi or Bluetooth Internet connection in home (for digital Wi-Fi enabled study scale)

Exclusion Criteria

* Self-reported major health conditions (e.g., heart disease, cancer, renal disease, and Type 1 or Type 2 diabetes)
* Current substance abuse
* Current treatment for serious psychiatric disorder (schizophrenia, bipolar disorder)
* Known fetal anomaly
* Planned termination of pregnancy
* Past history or current diagnosis of anorexia or bulimia
* Current use of one or more of the following medications:
* Metformin
* Systemic steroids
* Antipsychotic agents
* Anti-seizure medications or mood stabilizers that would be expected to have a significant impact on body weight
* Medications for ADHD including amphetamines and methylphenidate
* Any teratogenic agent Class D
* Participation in another dietary and/or weight management intervention during pregnancy
* Unwilling or unable to consume prepared meals delivered weekly
* Unable to understand and communicate in verbal and written English
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gareth R. Dutton PhD

Primary Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gareth Dutton, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Camille Worthington, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R21HD107325

Identifier Type: NIH

Identifier Source: secondary_id

View Link

IRB-300009275

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Self-Guided Personalized Treatment for Women
NCT05920720 NOT_YET_RECRUITING NA
A Study of Time Restricted Eating in Obese Adults
NCT05660291 ACTIVE_NOT_RECRUITING NA